Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.

The objective of this study was to ascertain the duration of tumor control and the toxicities of dose-intense myeloablative chemotherapy for patients with recurrent oligodendrogliomas. Patients with previously irradiated oligodendrogliomas, either pure or mixed, that were contrast enhancing, measura...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Cairncross, G., Swinnen, L., Bayer, R., Rosenfeld, S., Salzman, D., Paleologos, N., Kaminer, L., Forsyth, P., Stewart, D., Peterson, K., Hu, W., Macdonald, D., Ramsay, D., Smith, A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2000
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1919513/
https://ncbi.nlm.nih.gov/pubmed/11303620
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg